Open Access
REVIEW
Avetis Tsaturyan1,2, Heghine Hakobyan1, Kristina Hovsepyan1, Anna Mkrtchyan1,2, Tatevik Sargsyan1,2,*, Raffaele Pastore3, Germano Guerra3, Giovanni N. Roviello4,*
1 Scientific and Production Center ‘Armbiotechnology’ NAS RA, 14 Gyurjyan Str., Yerevan, Armenia
2 Institute of Pharmacy, Yerevan State University, 1 Alex Manoogian Str., Yerevan, Armenia
3 Department of Medicine and Health Sciences ‘Vincenzo Tiberio’, University of Molise, Via F. De Santis, Campobasso, Italy
4 Institute of Biostructures and Bioimaging (IBB) of the Italian National Council for Research (CNR), Area di Ricerca site and Headquarters, Via Pietro Castellino 111, Naples, Italy
* Corresponding Author: Tatevik Sargsyan. Email: ; Giovanni N. Roviello. Email:
(This article belongs to the Special Issue: Overcoming Drug Resistance in Cancer: Strategies and Natural Compound-Based Therapeutics)
Oncology Research https://doi.org/10.32604/or.2026.078405
Received 30 December 2025; Accepted 04 March 2026; Published online 10 April 2026
View
Download
Like
A pan-cancer analysis identifies SOAT1 as an immunological and prognostic biomarker
YANGQING HUANG, XINLAN ZHOU, XIUFEN...Apolipoprotein C1 promotes tumor progression in gastric cancer
QIOU GU, TIAN ZHAN, XIAO GUAN,...